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Summary. We analyze the problem of two clinically inseparable, repeatedly measured responses of
ordinal type by also incorporating their missingness process. In our application these are the thera-
peutic effect and extent of side effects of fluvoxamine. In case of a composite endpoint, the scientific
questions addressed can be answered only when the responses are modeled jointly. As an extension of
the methodology, several missing not at random models were fitted to a set of observed data and shown
to approximately yield the same result as their missing at random counterparts, although it affects pre-
cision. In addition, the effect of various identifying restrictions on multiple imputation is investigated. An
alternative numerical approximation method is suggested to reduce computational time.
Some Keywords: Fluvoxamine trial; Proportional odds mixed model; Missing not at random; Sensitivity
analysis; Multiple imputation.
1. Introduction
When conducting longitudinal studies, researchers have to deal with the complex structure of the
data as well as with the presence of incompleters. Also, some data types can turn out to be more
dicult to model than others. In addition, in many studies, especially in the medical realm, several
endpoints could not be regarded as separate responses but should be lumped into a single composite
endpoint.
This work is motivated by the uvoxamine trial, comprising data with two inseparable responses of
ordinal type, measured repeatedly over time, and where for some subjects values are missing. When
modelling, the rst aspect that needs to be taken into account is the longitudinal nature of the data.
Many statistical models have been developed for analyzing longitudinal data for which the random-
eects approach has been very popular for several decades (Laird and Ware (1982), Breslow and
Clayton (1993), Wolnger and O'Connell (1993) and Engel and Keen (1994)). In the uvoxamine
trial, after treating a patient with the drug, to characterize a patient's condition, the therapeutic
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eect and side eects were measured simultaneously. In such a context, joint modelling is preferred
over a separate analysis of dierent responses given that the former also allows every outcome to have
its own random eects and the association between dierent outcomes is captured by the correlation
between the random eects. The strong advantage is that it enables researcher to obtain answers to
various research questions, all from the same model. A wide variety of joint modelling techniques
have already been described: Thiebaut et al. (2002), Iddi and Molenberghs (2012), Rizopoulos 2012,
Fieuws and Verbeke (2006), Fieuws et al. (2006), Fieuws et al. (2008), Horrocks and van den Heuvel
(2009), Vasdekis et al. (2014), Molenberghs and Verbeke (2005). For an excellent, relatively early
review, we refer to the work of Tsiatis and Davidian (2004). However, the joint modelling of ordinal
responses received little attention.
Since in the uvoxamine trial, some of the patients did not appear at all scheduled ap-
pointments, as is often the case with empirical research, we had to deal with incomplete
data. From a methodological point of view, several aspects are important, rst of all, the modelling
framework: selection (SeM), pattern-mixture (PMM), and shared-parameter modelling (SPM) (for an
overview, see e.g. Molenberghs and Kenward 2007). Second, the mechanisms of missingness (Rubin
(1976)): the data can be Missing Completely at Random (MCAR) when the missingness is indepen-
dent of both the observed and unobserved data; Missing at Random (MAR) when, conditional on the
observed data, missingness is independent of the unobserved measurements; Missing Not at Random
(MNAR) when MCAR and MAR do not hold. In the PMM framework, the Multiple imputation (MI,
Rubin (1978), van Buuren (2007)) technique can be applied to analyze conveniently the data.
The main idea of MI is to investigate the eect of dierent identifying-restrictions strategies for the
incompleters.
1.1. Fluvoxamine Trial
The data are from a multicentre study involving 315 patients that were treated by uvoxamine for psy-
chiatric symptoms stemming from a dysregulation of serotonine in the brain. The data are discussed
in Molenberghs and Lesare (1994), Kenward et al. (1994), Molenberghs et al. (1997), Michiels and
Molenberghs (1997), and Molenberghs and Verbeke (2005). After their recruitment into the study,
patients were assessed at four visits. The therapeutic eect and the extent of side eects were scored
at each visit on an ordinal scale. The side eect response is coded as 1: none; 2: not interfering; 3:
interfering signicantly with functionality; 4: side eects surpasses the therapeutic eect. Similarly,
the eect of therapy is recorded on a four point ordinal scale: 1: no improvement or worsening;
2: minimal improvement; 3: moderate improvement and 4: important improvement. Hence, a side
eect is present when new symptoms occur and a therapeutic eect whenever old symptoms disap-
pear. A total of 299 patients with monotone sequences have at least one measurement, including
224 completers. A summary is given in Table 1. There is also baseline covariate information for
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Table 1. Fluvoxamine Trial. Number of observations with
side and therapeutic effect categories for each of the four
time points
# Observations
Ther. Eect Week 2 Week 4 Week 8 Week 12
0 19 64 110 135
1 95 114 93 62
2 102 62 30 19
3 83 29 10 10
Side Eect Week 2 Week 4 Week 8 Week 12
0 128 144 156 148
1 128 103 79 71
2 28 17 6 7
3 15 5 2 0
each subject, including gender, age, presence of psychiatric antecedents, initial severity of the disease,
duration of the actual mental illness. Obviously, one expects that the improvement of the patient's
condition as measured by the therapeutic eect is correlated with the side eects of the therapy, and
this association can only be studied if both outcomes are jointly modeled.
Furthermore, some of the patient proles had one or more missing observations for the therapeutic
and side eects. Note that, as these two outcomes were measured simultaneously, if a patient has
a missing value for the therapeutic eect, he/she will also have one for side eects, and vice versa.
The patterns of the missing data are summarized in Table 2. Among the incomplete sequences, the
dropout patterns are the more common ones. There are also 2 late-entry patients. Observe that there
are 14 subjects in total without any follow-up measurements. The latter are still an integral part of the
trial, as they provide baseline information, including covariate information and baseline assessment
of severity of mental illness. The scientic questions that are posed, considering the presence of
missingness, can be formulated as follows: Can the dierent assumptions about the mechanism of
the missingness and also the dierent identifying restrictions for the missing values lead to dierent
results?
1.2. Joint Modelling of Ordinal Response(s) and Process of Missingness
First, we will specify a model for a single ordinal response. A special case of GLMM, which is of
particular interest to this work, is the proportional odds mixed model (POMM) for ordinal outcomes
(Agresti and Lang 1993).
Consider a longitudinal outcome of ordinal type. Let Yij be the jth measurement of ith subject
(i = 1; : : : ; N , j = 1; : : : ; ni) with values r = 1; : : : ; R. Independence across subjects is further
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Table 2. Fluvoxamine Trial. Missing data patterns for side and therapeu-
tic effects where ’x’ denotes an observed measurement and ’?’ a missing
longitudinal response
Patient Week 2 Week 4 Week 8 Week 12 # Observations
1 x x x x 224
2 x x x ? 18
3 x x ? ? 26
4 x ? ? ? 31
5 ? ? ? ? 14
6 ? ? ? x 1
7 ? x x x 1
assumed. We rst dene R indicator variables as:
Wr;ij =
8<: 1 if Yij = r;0 otherwise:
Evidently, these are redundant but any subset of R  1 components is not. Group the dummies into
vectors W ij for a specic subject i and occasion j, and further into W i for all dummies across all
occasions for subject i. We further assume a multinomial distributionW ij  multinomial(ij), with
ij = (1;ij ; : : : ; r;ij ; : : : ; R;ij). The multinomial distribution at a given occasion is determined by
the modelling choice made for the ordinal outcome. The probabilities can be written as:
r;ij =
8>>><>>>:
1;ij if r = 1;
r;ij   r 1;ij if 1 < r < R;
1  R 1;ij if r = R;












0r + x0ij + z0ijbi
 :
Here, 01  : : :  0(R 1) are intercepts,  xed regression coecients, bi a vector of normally
distributed random eects, and xij (zij) the design vector for the xed (random) eects at occa-
sion j. Second, to deal with missingness, the subject-specic outcomes are summarized into a vector
Y i = (Yi1; Yi2; : : : ; Yini)
0 with observed (Y oi ) and missing components (Y
m
i ). In addition, for each
measurement j, we dene the missing data indicator as follows:
Rij =
8<: 1 if Yij is observed;0 otherwise:
Then, the Rijs can be grouped into a vector of missing data indicators Ri = (Ri1; Ri2; : : : ; Rini)
0,
which is evidently of the same length as Y i.
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To incorporate the missingness process into the modelling of an ordinal response, a joint model
is built by describing the joint density f(Y i;Ri) of vectors Y i and Ri. A very exible way forward
is by considering a mixed model for both outcomes and to allow the random eects in these to be
correlated. This allows for joint modelling of outcomes of a dierent nature and does not alter the
interpretation of the parameters in the sub-models for individual outcomes. This approach has been
applied already by Fieuws and Verbeke (2006) and Iddi and Molenberghs (2012), but not yet in
combination with ordinal outcomes.
For the case of an ordinal outcome, a POMM is assumed, as described before, while for the binary
missing data indicator a GLMM is assumed. Note also that the covariates in both models may, but
do not need to be the same. Let b1i and b2i be the vectors of random eects for the rst and second
responses, respectively. A joint model is now obtained by assuming a joint distribution for both sets
of random eects b1i and b2i. More specically, it will be assumed that bi = (b1i; b2i)
0 is normally
distributed with zero mean and covariance matrix G; the latter contains components to model the
association within each outcome sequence separately, as well as to model the association between
sequences. It will also be assumed that, conditionally on bi, the vectors Y i and Ri are independent,
i.e., we assume that their association is completely captured by the association between the random
eects.
Often a general unstructured matrix G is assumed, but specic restrictions can be imposed as
well. For example, perfect correlations between some of the elements in b1i and those in b2i would
lead to a joint model in which the random eects are shared between the two outcomes (Molenberghs
and Verbeke 2005). Evidently, this is equivalent to sharing components between b1i and b2i.
The estimation and inferences for all parameters in this joint model are based on standard likeli-
hood theory.
Further, an extension can be made to two or more ordinal outcomes. If all of them were measured
simultaneously, such as the therapeutic eect and the side eects from the uvoxamine trial, the
missing data indicator will be common to all outcomes, e.g., in the uvoxamine trial, R1i  R2i  Ri.
Considering as an example Table 2 of the uvoxamine trial, we can distinguish two patterns of
missingness, monotone and non-monotone. The former corresponds to the so-called dropouts {the
subject was excluded from the study before completion{, the latter to the late entries {some of the
initial response measurements were missing.
When restricting missingness to dropouts, the missing indicator Ri takes the form of (1, . . . , 1, 0,





Now, assume that we model the outcome yi and the missingness ri via two dierent sets of parameters:
 and  , respectively. Also, assume a common set of covariates xi, consisting of the union of the
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covariates inuencing the two processes. Then, f(yi; rijxi;; ) is the joint density of measurement
and missingness as described before. Dierent factorizations of this joint density lead to dierent
frameworks.
The selection model (SeM; Rubin 1976, Little and Rubin 2002) is based on the following factor-
ization of the joint density: f(yi; rijxi;; ) = f(yijxi;)f(rijxi;yi; ).
An alternative framework is the so-called pattern-mixture modelling (PMM; Little 1993, 1994):
f(yi; rijxi;; ) = f(yijxi; ri;)f(rijxi; ). PMM can be seen as a mixture of dierent populations,
characterized by the given pattern of missingness.
Further, instead of using SeM and PMM frameworks, the outcome and missingness processes can
be jointly modelled using a shared-parameter model (SPM; Wu and Carroll 1988, Follmann and Wu
1995, Little 1995, Njagi et al. 2014, Creemers et al. 2010), where the existence of a vector of shared
parameters bi is assumed: f(yi; rijxi; bi;; ) = f(yijxi; bi;)f(rijxi; bi; ).
A taxonomy of missing data mechanisms was introduced by Rubin (1976) and further devel-
oped by Little and Rubin (2002). It is based on the following conditional density of the miss-
ing process Ri: f(rijxi;yoi ;ymi ; ) and is easily developed in the selection setting. As a result,
three types of missing data mechanism have been dened (Verbeke and Molenberghs 2000, Fitzmau-
rice et al. 2004, Molenberghs and Kenward 2007): Missing Completely at Random (MCAR)
when the missingness is independent of both observed and unobserved data, which corresponds
to the factorization f(rijxi;yoi ;ymi ; ) = f(rijxi; ), Missing at Random (MAR) when con-
ditional on the observed data the missingness is independent of the unobserved measurements,
f(rijxi;yoi ;ymi ; ) = f(rijxi;yoi ; ), andMissing Not at Random (MNAR) when neither MCAR
nor MAR applies. Here, the conditional density will abide to the general form: f(rijxi;yoi ;ymi ; ).
Also, it was shown that, under the MAR assumption for modelling under the separability condi-
tions of the parameters  and  , the inference for these parameters based on likelihood is valid. This
property is known as ignorability , and brings us to the so-called direct likelihood analysis.
Another method for incorporating missingness into the data analysis is multiple imputation (MI)
that was formally introduced by Rubin (1978), who later published a comprehensive overview (Rubin
1987). For the continued development of the MI procedure we refer to sources such as Rubin and
Schenker (1986), Little and Rubin (2002), Schafer (2003), and van Buuren (2007). In Verbeke and
Molenberghs (2000), Molenberghs and Verbeke (2005), Molenberghs and Kenward (2007), Carpenter
and Kenward (2013) where several classical and more advanced MI techniques are described.
The main idea behind MI is to replace each missing measurement by a number of imputed values,
say M . These values are drawn from the distribution that incorporates the uncertainty about the
value to impute. Then, each one of theM imputed data sets is analyzed separately by using standard
procedures for complete data and the results of the analysis combined into a single one. In Rubin's
framework (1987), the imputations are drawn from the posterior distribution of the missing given
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the observed values.
As in selection modelling, a sensitivity analysis can also be conducted within the pattern-mixture
family. When investigating the structure of longitudinal data, we can conclude that the non-
completers stand out from the completers, especially in the case of early dropouts. Hence, it is
common to borrow information from other or even from all available patterns. For example, the
identifying restriction termed complete case missing values (CCMV), proposed by Little (1993), can
be assumed. Here, the unavailable information is always borrowed from the completers. For this
strategy to be stable there should be a suciently large number of completers. Alternatively, the
nearest identied pattern can be used. This restriction is referred to as neighboring case missing
values or NCMV (Verbeke and Molenberghs 2000, Molenberghs and Kenward 2007). However, using
information only from one pattern can be insucient, and hence, one can base the identication on all
available patterns for which the previous component is identied. This restriction is called available
case missing value (ACMV; Verbeke and Molenberghs 2000) and also corresponds to MAR, whereas
CCMV and NCMV are MNAR restrictions.
In contrast to Rubin's MI based on joint modelling of multiple longitudinal processes, Full Con-
ditional Specication (FCS) factorizes the multivariate distribution into a set of conditional densities
f(yj jy1; : : : ; yj 1) for each variable Yj . Strictly speaking, the conditional densities do not guarantee
the existence of a joint distribution of all variables. However, if we start from the well-specied joint
distribution, then the conditional ones can be straightforwardly derived from it. The key assump-
tion of FCS is ignorability { the conditional densities for Y mj given Y
o
j do not depend
on missing patterns{ but the method can be easily extended to MNAR when specifying
the number of identifying restrictions.
As to the choice of the number of imputations, the early literature suggests that a small numberM
of imputations, generally in the 3{5 range, is adequate because the larger the number of imputations
the smaller the increase in eciency (Rubin and Schenker 1986, Rubin 1987). However, recent publi-
cations pointed out that small M values lead to results that are aected by Monte Carlo error: using
the same M , the point and precision estimates may vary considerably if the MI analysis is repeated
with a dierent set of imputations (White et al. 2011, van Buuren 2012), especially when outcomes
are non-Gaussian and/or focus is on hypothesis testing. Hence, a larger number of imputations is
preferable.
2. Analysis of Fluvoxamine Trial
2.1. Direct Likelihood Analysis
Recall from Section 1.1 that the study encompasses four time points, at each one of which side eects
and therapeutic eect are assessed on a 4-point ordinal scale. Note that the missing-data patterns
occurring are mostly of the monotone type. For this reason we exclude the two non-monotone
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sequences.
Let Y kij be the score for patient i at time point j, k = 1; 2 for therapeutic and side eects. The
proportional odds logistic regression with random intercept for the kth response can be expressed as
follows:
logit[P (Y kij  r)] = k;0r + bki + k;11t1ij + k;12t2ij + k;13t3ij + k;2X1i
+ : : :+ k;5X4i; (1)
where t1ij , t2ij , and t3ij are dummies corresponding to weeks 4, 8, and 12, respectively. Clinically, one
cannot separate therapeutic eect from side eects, because the former refers to the disappearance of
existing symptoms, whereas the latter corresponds to emerging symptoms. To capture the association
between the responses, various assumptions about the distribution of the random eects can be made.









The t is presented as Model 0 in Tables 3 and 4. This analysis is performed under ignorability.
2.2. Analysis under Missing Not at Random Assumption
Next, we perform a sensitivity analysis under MNAR. Without loss of generality, we assume that the
missingness process can be modeled using the same set of covariates as the two outcomes of scientic
interest. The following logistic regression can be specied for the missing indicator:
logit[P (Di > j)] = 3;0 + b3i + 3;11t1ij + 3;12t2ij + 3;13t3ij + 3;2X1i + : : :+ 3;5X4i: (3)
Let the side and therapeutic eects be modeled as in (1). To capture the association between (1) and
(3), we consider the following options:
(1) allowing b3i to be pairwise correlated with b1i and b2i (Model 1);
(2) shared modelling by considering random eects for both outcomes b1i and b2i, shared with the
missing indicator, scaled by factors 1 and 2. This corresponds to Model 2 in Tables 3 and 4.
Hence, the logistic regression for the missing data indicator takes the following form:
logit[P (Di > j)] = 3;0 + 1b1i + 2b2i + 3;11t1ij + 3;12t2ij + 3;13t3ij + 3;2X1i
+ : : :+ 3;5X4i;
(3) modelling the association between missingness and every outcome by including two extra random
intercepts: b3i for the therapeutic eect and b4i for the side eects. Further, the missingness
process will be associated with the outcomes through these shared random intercepts b3i and
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b4i, which are again included using scale factors 3 and 4. Then, the model for the missingness
process can be written as follows:
logit[P (Di > j)] = 3;0 + 3b3i + 4b4i + 3;11t1ij + 3;12t2ij + 3;13t3ij + 3;2X1i
+ : : :+ 3;5X4i:
See Model 3 in Tables 3 and 4.
These models exhibit the following hierarchical relationships: the most complex model is model 3,
containing model 1 as a sub-model, with model 2 a further sub-model of the latter. For more details
about model-specic variance-covariance matrices of the random eects structure, see Supplementary
Materials B, matrices (4){(6). The most complex model 3 is overspecied, but can be used as a basis
for sensitivity analysis, and as a resource to select identied sub-models.
Model 1 had computational issues and was further discarded. Models 2 and 3 were implemented
in the NLMIXED procedure of SAS 9.4, where numerical integration adaptive Gaussian quadrature
was used with Q = 10. We paid special attention to tting Model 3 given its complexity. The results
will be discussed in Section 2.3.
When comparing the tted models of Tables 3 and 4, we observe that the parameter estimates
for the xed eects of the therapeutic and the side eects are approximately the same for all three
models. As to the random part, Model 2 yields slightly larger estimates than Model 0, whereas
Model 3 generates slightly lower estimates than Model 0. The similarity of the results for Model 0
under MAR and Models 2 and 3 under MNAR conrms the observation of Molenberghs et al. (2008).
These authors showed a strong connection between the MNAR model t and the MAR model t.
The most important conclusion was that the MNAR model tted to a set of observed data can be
reproduced by a MAR counterpart, which is in our case Model 0. However, sometimes it happens
that the parametric MAR model does not properly t the observed data. It is therefore of interest to
t a suciently dierent MNAR model to ensure a good t to the observed data and then examine
the corresponding MAR version. In addition, these authors concluded that the MNAR and MAR
models produce dierent predictions for unobserved outcomes, given the observed ones.
Further observations concern the standard errors of the estimates: given that the missing data
mechanism is incorporated, the standard error estimates of all parameters increase compared to those
of the model under MAR. It means that Models 2 and 3 are less ecient than Model 0, and in case
of prediction the uncertainty will be larger.
2.3. Additional Investigation of Model 3
Implementing Model 3 leads to some computational problems due to its complexity. Here, the ther-
apeutic and side eects are modeled jointly as described in Section 2.1 and, to add the missingness
process to this joint modelling, two extra random intercepts: b3i for the therapeutic eect, and b4i for
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Table 3. Fluvoxamine Trial. Response-specific parameter estimates (s.e.) of
the regression coefficients. Model 0: model with two outcomes only; Model
2: model with two random intercepts both of which are shared with missing
data indicator; Model 3: model with four random intercepts of which two are
shared with missing data indicator
Est. (s.e.) Est. (s.e.) Est. (s.e.)
Eect Par. Model 0 Model 2 Model 3
Therapeutic Eect
int. 0 1;00  2.16 (1.18)  2.25 (1.23)  2.27 (1.23)
int. 1 1;01 1.03 (1.18) 0.93 (1.26) 0.91 (1.26)
int. 2 1;02 3.42 (1.19) 3.33 (1.31) 3.31 (1.32)
time (week = 4) 1;11 2.07 (0.20) 2.04 (0.20) 2.04 (0.20)
time (week = 8) 1;12 3.60 (0.25) 3.55 (0.25) 3.55 (0.25)
time (week = 12) 1;13 4.48 (0.28) 4.42 (0.29) 4.42 (0.29)
antecedents 1;2  0.31 (0.34)  0.35 (0.34)  0.35 (0.34)
age=30 1;3  0.18 (0.37)  0.20 (0.38)  0.20 (0.38)
duration=100 1;4  0.87 (0.77)  0.87 (0.78)  0.85 (0.78)
initial severity 1;5  0.27 (0.21)  0.25 (0.22)  0.24 (0.22)
RI sd.
p
d11 2.35 (0.18) 2.37 (0.19) 1.88 (0.41)
RI sd.
p
g33 | | 1.45 (0.50)
Side Eects
int. 0 2;00  1.71 (1.68)  2.16 (1.83)  1.83 (1.84)
int. 1 2;01 3.29 (1.69) 2.81 (1.87) 3.17 (1.89)
int. 2 2;02 5.64 (1.72) 5.15 (2.01) 5.62 (2.05)
time (week = 4) 2;11 0.74 (0.23) 0.66 (0.23) 0.65 (0.23)
time (week = 8) 2;12 1.58 (0.26) 1.45 (0.26) 1.45 (0.26)
time (week = 12) 2;13 1.64 (0.27) 1.48 (0.27) 1.48 (0.27)
antecedents 2;2  0.12 (0.49)  0.22 (0.50)  0.25 (0.51)
age=30 2;3  1.56 (0.54)  1.58 (0.57)  1.68 (0.58)
duration=100 2;4  3.97 (1.08)  3.95 (1.11)  3.96 (1.12)
initial severity 2;5 0.74 (0.30) 0.83 (0.32) 0.79 (0.32)
RI sd.
p
g22 3.39 (0.30) 3.47 (0.34) 2.29 (0.57)
RI sd.
p
g44 | | 2.66 (0.49)
Missing Indicator
int. 3;0 |  2.90 (0.99)  3.59 (1.36)
time (week = 4) 3;11 | 0.93 (0.36) 1.25 (0.43)
time (week = 8) 3;12 | 1.17 (0.37) 1.70 (0.51)
time (week = 12) 3;13 | 0.97 (0.40) 1.61 (0.58)
antecedents 3;2 | 0.34 (0.29) 0.45 (0.36)
age=30 3;3 | 0.39 (0.30) 0.54 (0.38)
duration=100 3;4 | 1.67 (0.50) 2.09 (0.69)
initial severity 3;5 |  0.32 (0.16)  0.41 (0.20)
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Table 4. Fluvoxamine Trial. Common parameter estimates (s.e.)
of the regression coefficients. Model 0: model with two outcomes
only; Model 2: model with two random intercepts both of which are
shared with missing data indicator; Model 3: model with four ran-
dom intercepts of which two are shared with missing data indicator
Est. (s.e.) Est. (s.e.) Est. (s.e.)
Eect Par. Model 0 Model 2 Model 3
Therapeutic Eect & Side Eects
Cov. RI's g12 0.96 (0.64) 1.17 (0.67) 1.09 (0.67)
Therapeutic Eect & Missing Indicator
RI sd.
p
g11 | 2.37 (0.19) |
RI sd.
p
g33 | | 1.45 (0.50)
Scale 1 |  1.13 (0.07) |
Scale 3 | |  0.53 (0.40)
Side Eects & Missing Indicator
RI sd.
p
g22 | 3.47 (0.34) |
RI sd.
p
g44 | | 2.66 (0.49)
Scale 2 |  0.23 (0.05) |
Scale 4 | |  0.50 (0.20)
the side eects are included. Further, the missingness process will be associated with the outcomes
through these shared random intercepts b3i and b4i, which are included using scale factors 3 and 4.
Using the SAS procedure NLMIXED, we t a joint POMM{POMM{GLM model by relying on
numerical integration. In NLMIXED, not only several integration techniques are available,
but also a number of optimization algorithms. Having experienced problems with the default
quasi-Newton optimization algorithm, we replaced it by the more stably converging Newton-Raphson
algorithm. Further, given the latter, a numerical sensitivity analysis for dierent integral approxima-
tions was performed. Here, we investigated the inuence on model t not only stemming from the
approximation method but also the a priori selected number of quadrature points. More precisely,
we initiated the model tting using adaptive Gaussian quadrature approximation for Q = 3; 5; 10.
The dierence between adaptive and non-adaptive Gaussian quadrature is that for the former the
quadrature points are appropriately centered and scaled in a way that more quadrature points lie
in the region with high probability mass, while for the latter the quadrature points are centered at
zero for each of the random eects, and the current random-eects covariance matrix is used as scale
matrix (Molenberghs and Verbeke 2005). Clearly, the adaptive Gaussian quadrature approximation
is much more time consuming. Subsequently we switched to non-adaptive Gaussian quadrature, and
tted the model for Q = 10; 20. The results are summarized in Tables 5 and 6.
The following observations can be made. Within the adaptive Gaussian quadrature approximation,
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there is a minor dierence in the parameter estimates (except for some intercepts), also in one of the
standard errors, between Q = 5 and Q = 10. This is also conrmed in terms of log-likelihood. The
deviation between the t for Q = 3 and Q = 5; 10 is much more visible both in terms of the estimates
and the log-likelihood value (the 2log-likelihood is higher). Switching to non-adaptive approximation
and comparing the point and precision estimates and  2log-likelihood, we reach practically the same
t for Q = 10 and Q = 20. These approximations are also numerically close to the adaptive Gaussian
quadrature approximation with Q = 10, and hence, based on the previous comparison, they are also
similar to those of the same method but with Q = 5. However, the most important advantage of
replacing the adaptive approximation by the non-adaptive one is the gain in computation time. As all
mentioned modications of model tting were applied using the same computer platform, a similar
way of programming, and the same starting values, we can make a fair comparison of computation
times. We observed that almost without losing any quality of the model t, we can switch from
adaptive to non-adaptive Gaussian quadrature, both with Q = 10. As a result, the computation
time decreased from more than 81 hours to approximately 1 hour. However, in the context of the
uvoxamine data and the model considered, adaptive quadrature with Q = 5 is a feasible technique:
the quality of the approximation is almost the same as with the latter method and the computation
time is a little over 5 hours, which is not unreasonable.
In addition, we investigated whether we can reduce the computation time even more when using
as starting parameters for non-adaptive Gaussian approximation with Q = 20 the estimated values
from the same procedure but with Q = 10. However, we observed that this was not a promising
route: the model t was almost the same as for Q = 10 and the implementation ran at approximately
the same speed.
Given that the models considered have a likelihood basis, they can be compared using likelihood
ratio or related tests when they are nested, or using information criteria when they are not. How-
ever, because data are incomplete, one should also investigate the sensitivity of inferences drawn to
necessarily non-veriable assumptions about the predictive distribution, i.e., the distribution of the
unobserved data, given observed data, covariates, and the missing data mechanism. Indeed, models
with the same or similar t to the observed data can strongly dier in terms of the predictive dis-
tribution (Molenberghs et al., 2008). Verbeke, Molenberghs, and Beunckens (2008) presented formal
and informal model selection and model assessment tool for such cases. The fact that we present
several models with diering assumptions about the relationships between outcome and missingness
processes can be seen as a component of such a sensitivity analysis.
2.4. Multiple Imputation and Sensitivity Analysis
Multiple imputation, at least in its basic form (Rubin 1978) requires the missingness mechanism to
be MAR. That is why we started our investigation with the ACMV method that works under MAR.
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Table 5. Fluvoxamine Trial. Response-specific parameter estimates (s.e.) of the regression coefficients
of Model 3 with four random intercepts, two of which are shared. The results are listed for adaptive
(Q=3, 5, 10) and non-adaptive Gaussian quadrature (Q=10, 20)
Est. (s.e.) Est. (s.e.) Est. (s.e.) Est. (s.e.) Est. (s.e.)
Adaptive Non{Adaptive
Eect Par. Q = 3 Q = 5 Q = 10 Q = 10 Q = 20
Therapeutic Eect
int. 0 1;00  1.68 (1.24)  2.21 (1.23)  2.27 (1.23)  2.21 (1.25)  2.26 (1.23)
int. 1 1;01 1.52 (1.28) 0.97 (1.26) 0.91 (1.26) 0.97 (1.28) 0.92 (1.26)
int. 2 1;02 3.94 (1.36) 3.37 (1.32) 3.31 (1.32) 3.37 (1.34) 3.31 (1.31)
time (week = 4) 1;11 2.05 (0.20) 2.04 (0.20) 2.04 (0.20) 2.05 (0.20) 2.04 (0.20)
time (week = 8) 1;12 3.57 (0.25) 3.55 (0.25) 3.55 (0.25) 3.56 (0.25) 3.55 (0.25)
time (week = 12) 1;13 4.44 (0.29) 4.42 (0.29) 4.42 (0.29) 4.43 (0.29) 4.42 (0.29)
antecedents 1;2  0.35 (0.34)  0.35 (0.34)  0.35 (0.34)  0.34 (0.34)  0.35 (0.34)
age=30 1;3  0.28 (0.38)  0.21 (0.38)  0.20 (0.38)  0.20 (0.38)  0.20 (0.38)
duration=100 1;4  0.86 (0.78)  0.86 (0.78)  0.85 (0.78)  0.86 (0.78)  0.85 (0.78)
initial severity 1;5  0.34 (0.22)  0.25 (0.22)  0.24 (0.22)  0.25 (0.22)  0.24 (0.22)
RI sd.
p
g11 1.93 (0.41) 1.87 (0.40) 1.88 (0.41) 1.93 (0.42) 1.89 (0.41)
RI sd.
p
g22 1.37 (0.54) 1.46 (0.48) 1.45 (0.50) 1.37 (0.58) 1.43 (0.51)
Side Eects
int. 0 2;00  1.70 (1.77)  1.80 (1.82)  1.83 (1.84)  0.93 (2.35)  1.83 (1.83)
int. 1 2;01 3.23 (1.82) 3.20 (1.87) 3.17 (1.89) 4.13 (2.48) 3.18 (1.88)
int. 2 2;02 5.64 (1.98) 5.63 (2.03) 5.62 (2.05) 6.64 (2.71) 5.62 (2.04)
time (week = 4) 2;11 0.66 (0.23) 0.66 (0.23) 0.65 (0.23) 0.66 (0.23) 0.65 (0.23)
time (week = 8) 2;12 1.46 (0.26) 1.45 (0.26) 1.45 (0.26) 1.46 (0.26) 1.45 (0.26)
time (week = 12) 2;13 1.49 (0.27) 1.48 (0.27) 1.48 (0.27) 1.49 (0.27) 1.48 (0.27)
antecedents 2;2  0.22 (0.49)  0.24 (0.50)  0.25 (0.51)  0.42 (0.52)  0.25 (0.50)
age=30 2;3  1.64 (0.55)  1.67 (0.57)  1.68 (0.58)  1.91 (0.62)  1.67 (0.57)
duration=100 2;4  3.91 (1.08)  3.96 (1.11)  3.96 (1.12)  4.02 (0.96)  3.96 (1.13)
initial severity 2;5 0.75 (0.31) 0.78 (0.32) 0.79 (0.32) 0.70 (0.36) 0.77 (0.32)
RI sd.
p
g33 2.35 (0.46) 2.39 (0.54) 2.29 (0.57) 2.37 (0.45) 2.32 (0.56)
RI sd.
p
g44 2.40 (0.48) 2.50 (0.50) 2.66 (0.49) 2.67 (0.40) 2.64 (0.50)
Missing Indicator
int. 3;0  3.67 (1.37)  3.61 (1.37)  3.59 (1.36)  3.82 (1.41)  3.61 (1.37)
time (week = 4) 3;11 1.24 (0.43) 1.25 (0.43) 1.25 (0.43) 1.25 (0.43) 1.25 (0.44)
time (week = 8) 3;12 1.69 (0.51) 1.70 (0.51) 1.70 (0.51) 1.70 (0.50) 1.71 (0.51)
time (week = 12) 3;13 1.60 (0.58) 1.62 (0.58) 1.61 (0.58) 1.62 (0.57) 1.62 (0.58)
antecedents 3;2 0.45 (0.37) 0.45 (0.37) 0.45 (0.36) 0.49 (0.37) 0.45 (0.37)
age=30 3;3 0.55 (0.38) 0.54 (0.38) 0.54 (0.38) 0.59 (0.38) 0.54 (0.38)
duration=100 3;4 2.10 (0.70) 2.10(0.70) 2.09 (0.69) 2.10 (0.67) 2.10 (0.69)
initial severity 3;5  0.39 (0.20)  0.41 (0.20)  0.41 (0.20)  0.38 (0.21)  0.41 (0.20)
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Table 6. Fluvoxamine Trial. Common parameter estimates (s.e.) of the regression coefficients of
Model 3 with four random intercepts, two of which are shared. The results and comutation time are
listed for adaptive (Q=3, 5, 10) and non-adaptive Gaussian quadrature (Q=10, 20)
Est. (s.e.) Est. (s.e.) Est. (s.e.) Est. (s.e.) Est. (s.e.)
Adaptive Non{Adaptive
Eect Par. Q = 3 Q = 5 Q = 10 Q = 10 Q = 20
Therapeutic Eect & Side Eects
Cov. RI's g12 1.05 (0.64) 1.06 (0.66) 1.09 (0.67) 0.88 (0.71) 1.07 (0.68)
Therapeutic Eect & Missing Indicator
RI sd.
p
g22 1.37 (0.54) 1.46 (0.48) 1.45 (0.50) 1.37 (0.58) 1.43 (0.51)
Scale 1  0.58 (0.45)  0.49 (0.35)  0.53 (0.40)  0.56 (0.49)  0.54 (0.41)
Side Eects & Missing Indicator
RI sd.
p
g44 2.40 (0.48) 2.50 (0.50) 2.66 (0.49) 2.67 (0.40) 2.64 (0.50)
Scale 4  0.58 (0.22)  0.57 (0.23)  0.50 (0.20)  0.51 (0.17)  0.52 (0.20)
-2ll 3981.0 3975.4 3974.3 3973.7 3974.2
CPU 42:07 5:07:30 81:26:54 1:00:04 15:23:35
Given that current computational facilities support larger numbers of M to be used at minimal cost
(except maybe for very large datasets), it seems reasonable to choose M in such a way that the nal
analysis is reproducible, i.e., if one wants to repeat the analysis for the same M then essentially the
same results will be generated. Hence, all MI methods implemented by us were ran for M = 20
imputations. In the Supplementary Materials A, we show that M = 10 returns essentially the same
results.
The ACMV analysis was implemented as follows: rst the procedure MI (SAS 9.4) is used for the
imputations, then every completed data is analysed using procedure NLMIXED for the joint modelling
of the therapeutic and side eects with the general assumption for the covariance matrix (2), and
nally the results of the separate analysis are combined into a single one using the MIANALYZE
procedure.
Further, one might want to examine how the MAR and MNAR models dier in their prediction
of unobserved data. Another interesting point is how the results depend on the way the multivariate
distribution of the longitudinal process is treated. To compare the results of the analysis, given the
dierent hypotheses about the identifying restriction for missing data, we will perform a sensitivity
analysis for the multiple imputation (Carpenter et al. 2013).
Since at the end of the study, as a number of patients dropped out, the variability of side eects
and therapeutic eect turned out to be insucient to include both variables into the MI analysis.
Given the fact that with high side eects a reasonable therapeutic eect is absent, we decided to
remove the last (i.e., the 5th) measurement of the therapeutic eect in the MI analysis.
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Based on the joint density for the observed and missing data, we will perform the MI analysis given
identifying restrictions MI 1{3. MI 4 is an identifying restriction based on a conditional distribution
f(yj jy1; : : : ;yj 1), where for each variable Y j we assume it to be the same for Y oj and Y mj :
(MI 1) under MAR: available cases missing value (ACMV) method.
(MI 2) under MNAR: neighboring case missing values (NCMV). In this method, for the imputed missing
values of variable Y j , we estimated the posterior density based on the patterns for which Y j is
observed and Y j+1 is missing. The mentioned principle for identifying Y j can be extended to
larger numbers of patterns: the patterns for which Y j is observed and Y j+k is missing.
(MI 3) under MNAR: complete case missing value (CCMV).
(MI 4) under MAR: the Full Conditional Specication (FCS; van Buuren 2007) method was applied.
Here, it was assumed that, if the patient left the study, all his/her \after dropout" measurements
are equal to the overall mean.
All aforementioned modications of the MI analysis (MI 1{4) where implemented in SAS (SAS 9.4)
in the same way as described in the beginning of this section. The results for the point and precision
estimates are listed in Table 7. We note that FCS and ACMV are closest to each other in terms of
estimates and precision estimates. This is to be expected, given their MAR basis. CCMV generates
approximately the same results except for the category-specic intercepts: they are slightly dierent
but have almost the same precision as with FCS and ACMV.
When compared with CCMV, FCS, and ACMV, NCMV generates slightly dierent approxima-
tions for the xed eects and also for the standard deviations of the random intercepts. However, the
largest dierence lies in the estimation of the covariance between the random intercepts of the two
responses: for NCMV the covariance is much higher. It can be explained by NCMV: here, we dened
the posterior density by the neighboring patterns, which by nature are more similar to each other,
hence, the higher correlation between the joint responses. The precision estimates of all parameters
for NCMV are approximately the same as for the other methods.
3. Discussion
In this article, we proposed an application of the joint modelling of composite endpoint method on
the uvoxamine trial, a study with two longitudinal ordinal outcomes where not all patients remained
in the study. Since the therapeutic and side eects were measured simultaneously, they were regarded
as components of a composite endpoint and had to be modelled jointly. Then, we extended our model
by incorporating missingness in various ways to estimate the eect on the results.
After applying several MNAR models, we concluded that they yield approximately the same t as
their MAR counterpart but with a slightly higher uncertainty. This ensures that the corresponding
MAR version properly ts the observed data. For simplicity, the models formulated include only
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Table 7. Fluvoxamine Trial. Parameter estimates (s.e.) of the regression coefficients for
available case missing value (ACMV), neighboring case missing value (NCMV), complete
case missing value (CCMV) and full conditional specification (FCS) multiple imputation. All
are performed forM = 20 imputations
Est. (s.e.) Est. (s.e.) Est. (s.e.) Est. (s.e.)
Eect Par. ACMV NCMV CCMV FCS
Therapeutic Eect
int. 0 1;00  2.03 (1.14)  2.27 (1.13)  1.96 (1.10)  2.00 (1.08)
int. 1 1;01 1.01 (1.15) 0.56 (1.13) 1.13 (1.10) 1.06 (1.08)
int. 2 1;02 3.40 (1.16) 2.75 (1.13) 3.55 (1.10) 3.45 (1.10)
time (week = 4) 1;11 1.99 (0.19) 1.74 (0.18) 2.06 (0.19) 2.01 (0.19)
time (week = 8) 1;12 3.50 (0.24) 2.60 (0.21) 3.62 (0.24) 3.52 (0.24)
time (week = 12) 1;13 4.32 (0.27) 3.86 (0.25) 4.41 (0.27) 4.34 (0.27)
antecedents 1;2  0.27 (0.31)  0.65 (0.32)  0.24 (0.32)  0.24 (0.31)
age=30 1;3  0.13 (0.36)  0.37 (0.35)  0.03 (0.35)  0.11 (0.34)
duration=100 1;4  0.75 (0.72)  1.13 (0.74)  0.64 (0.72)  0.73 (0.71)
initial severity 1;5  0.29 (0.20)  0.09 (0.20)  0.35 (0.19)  0.31 (0.19)
RI sd.
p
g11 2.24 (0.17) 2.34 (0.17) 2.25 (0.16) 2.24 (0.17)
Side Eects
int. 0 2;00  0.72 (1.55)  1.25 (1.57)  0.44 (1.48)  0.94 (1.57)
int. 1 2;01 3.87 (1.53) 2.78 (1.59) 4.29 (1.49) 3.72 (1.57)
int. 2 2;02 6.54 (1.55) 4.90 (1.63) 6.84 (1.53) 6.48 (1.59)
time (week = 4) 2;11 0.76 (0.23) 0.42 (0.21) 0.91 (0.22) 0.78 (0.22)
time (week = 8) 2;12 1.51 (0.24) 0.59 (0.23) 1.69 (0.25) 1.52 (0.24)
time (week = 12) 2;13 1.59 (0.26) 0.80 (0.23) 1.71 (0.25) 1.62 (0.25)
antecedents 2;2  0.03 (0.45)  0.52 (0.46) 0.07 (0.44) 0.01 (0.46)
age=30 2;3  1.49 (0.49)  1.37 (0.50)  1.47 (0.47)  1.50 (0.49)
duration=100 2;4  3.81 (0.99)  4.74 (1.02)  3.48 (0.95)  4.00 (1.00)
initial severity 2;5 0.52 (0.28) 0.71 (0.27) 0.44 (0.26) 0.56 (0.27)
RI sd.
p
g22 3.10 (0.30) 3.26 (0.29) 3.08 (0.26) 3.19 (0.28)
Common parameter
Therapeutic Eect & Side Eects
Cov. RI's g12 0.83 (0.53) 2.58 (0.66) 0.86 (0.53) 0.90 (0.57)
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random intercepts. They can be extended to models with more complex random eect structures,
e.g., models with random intercepts and random slopes. Potentially, this may increase complexity of
convergence as well as computation time. We paid specic attention to the complexity of the POMM{
POMM{GLMMNARmodel. We found that an acceptable model t and reasonable computation time
can be obtained for non-adaptive Gaussian quadrature numerical approximation with Q = 10. Also,
adaptive quadrature with Q = 5 is feasible in the context of the study. While adaptive quadrature
with a suciently large number of quadrature points is recommended, the achieved accuracy and
numerical feasibility will depend on the application at hand.
Given the assumptions behind the posterior distribution of the dropouts, dierent modications
of MI analysis were introduced. As such assumptions are partly untestable, conducting a sensitivity
analysis is primordial. Starting with the basic MI analysis in its MAR form (Rubin 1978) and
then extended to MNAR, under a suite of the identifying restrictions (Verbeke and Molenberghs
2000, Molenberghs and Kenward 2007, van Buuren 2007), we concluded that, based on the performed
sensitivity analysis, in the context of the uvoxamine trial, inferences regarding some parameters can
be modied by some identifying restrictions. After comparing all MI analysis performed, we conclude
that the largest dierence in inference is for NCMV and is due to the much larger estimates of
the covariance between the random intercepts of the two responses. This can be explained by the
denition of the posterior density as it considers neighboring patterns which are bound to be similar.
The guideline for choosing the number of imputations is to render the nal analysis reproducible,
which is not always the case for a small number of imputations (White et al. 2011, van Buuren 2012).
Hence, a suciently large number of imputations is advised (e.g., M = 20) and supported by the
currently available computational power.
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Table 8. Fluvoxamine Trial. Parameter estimates (s.e.) of the regression coefficients for
available case missing value (ACMV), neighboring case missing value (NCMV), complete
case missing value (CCMV) and full conditional specification (FCS) multiple imputation. All
are performed forM = 10 imputations
Est. (s.e.) Est. (s.e.) Est. (s.e.) Est. (s.e.)
Eect Par. ACMV NCMV CCMV FCS
Therapeutic Eect
int. 0 1;00  1.98 (1.10)  2.29 (1.12)  2.09 (1.08)  2.04 (1.11)
int. 1 1;01 1.06 (1.11) 0.54 (1.12) 0.99 (1.07) 1.04 (1.12)
int. 2 1;02 3.44 (1.12) 2.69 (1.13) 3.39 (1.09) 3.45 (1.13)
time (week = 4) 1;11 2.00 (0.19) 1.72 (0.18) 2.07 (0.19) 2.02 (0.19)
time (week = 8) 1;12 3.48 (0.25) 2.60 (0.20) 3.62 (0.23) 3.53 (0.24)
time (week = 12) 1;13 4.32 (0.27) 3.84 (0.24) 4.40 (0.27) 4.36 (0.27)
antecedents 1;2  0.28 (0.31)  0.62 (0.32)  0.21 (0.31)  0.24 (0.32)
age=30 1;3  0.12 (0.35)  0.39 (0.35)  0.01 (0.34)  0.11 (0.35)
duration=100 1;4  0.69 (0.72)  1.29 (0.72)  0.83 (0.70)  0.85 (0.72)
initial severity 1;5  0.30 (0.19)  0.07 (0.19)  0.32 (0.19)  0.30 (0.20)
RI sd.
p
g11 2.23 (0.17) 2.32 (0.17) 2.23 (0.17) 2.29 (0.17)
Side Eects
int. 0 2;00  0.85 (1.51)  1.17 (1.53)  0.50 (1.46)  1.02 (1.57)
int. 1 2;01 3.75 (1.50) 2.90 (1.54) 4.23 (1.48) 3.68 (1.58)
int. 2 2;02 6.42 (1.54) 5.04 (1.55) 6.77 (1.52) 6.35 (1.64)
time (week = 4) 2;11 0.75 (0.23) 0.43 (0.20) 0.89 (0.21) 0.76 (0.21)
time (week = 8) 2;12 1.50 (0.26) 0.62 (0.22) 1.69 (0.24) 1.52 (0.24)
time (week = 12) 2;13 1.61 (0.26) 0.84 (0.22) 1.77 (0.23) 1.61 (0.25)
antecedents 2;2  0.03 (0.44)  0.52 (0.48) 0.11 (0.45) 0.06 (0.44)
age=30 2;3  1.49 (0.50)  1.45 (0.50)  1.48 (0.48)  1.52 (0.48)
duration=100 2;4  3.87 (1.01)  4.81 (1.03)  3.60 (0.96)  4.09 (0.99)
initial severity 2;5 0.55 (0.27) 0.72 (0.27) 0.46 (0.26) 0.58 (0.27)
RI sd.
p
g22 3.12 (0.30) 3.28 (0.26) 3.11 (0.28) 3.19 (0.26)
Common parameter
Therapeutic Eect & Side Eects
Cov. RI's g12 0.84 (0.53) 2.57 (0.63) 0.81 (0.54) 1.02 (0.60)
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B. Variance-Covariance Matrices of Random-Effects Structures







Model 2: The random intercepts for both outcomes, b1i and b2i, are shared with the missing-data











Model 3: The random intercepts are b3i for therapeutic eect and b4i for side eects; missingness




g11 + g33 + 2g13 g12 + g14 + g23 + g24 1g13 + 1g33 + 2g14 + 2g34
g12 + g14 + g23 + g24 g22 + g44 + 2g24 1g23 + 1g34 + 2g24 + 2g44
1g13 + 1g33 + 2g14 + 2g34 1g23 + 1g34 + 2g24 + 2g44 
2
1
g33 + 
2
2
g34 + 212g34
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(6)
